bcg tice
Vaccineexperimental
Clinical trial activity
13 trials · 25 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
9
Phase 3
2
Phase 4
1
Earliest trial started Dec 1, 2010 (NCT01340820)
Timeline
Indications
Approved for
Studied for
- BCG Vaccine · Phase 2
- Bronchiectasis · Phase 2
- Carcinoma, Transitional Cell · Phase 2
- COVID-19 · Phase 3
- Cystic Fibrosis · Phase 2
- Gallbladder Neoplasms · Phase 1/Phase 2
- HIV Infections · Phase 2
- Infant Mortality · Phase 4
- Mycobacterium avium-intracellulare Infection · Phase 2
- Mycobacterium bovis · Phase 4
- Mycobacterium Infections, Nontuberculous · Phase 2
- Nontuberculous Mycobacteria · Phase 2
- Tuberculosis · Phase 1
- Urinary Bladder Neoplasms · Phase 3
Mechanism of action
- Mycobacterium tuberculosisImmunity, active
Mycobacterium tuberculosis immunity, active
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07094711 | Phase 2 | Sep 30, 2025 | University of Virginia |
| NCT07064863 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2025 | Queen's University, Belfast |
| NCT07000084 | Phase 3 | Jul 17, 2025 | National Cancer Institute (NCI) |
| NCT06704191 | Phase 1/Phase 2 (Phase 2) | Dec 6, 2024 | Mayo Clinic, National Center for Advancing Translational Science (NCATS) |
| NCT05124340 | Phase 2 | Dec 15, 2021 | Airlangga University, Dr. Soetomo General Hospital, PT Bio Farma |
| NCT05004038 | Phase 2 | Oct 31, 2021 | University of Zurich |
| NCT04884308 | Phase 2 | Apr 28, 2021 | Cystic Fibrosis Foundation, Johns Hopkins University |
| NCT04658680 | Phase 4 | Feb 25, 2021 | Bandim Health Project, University Hospital Bispebjerg and Frederiksberg, University of Copenhagen, University of Southern Denmark |
| NCT04496219 | Phase 2 | Jan 22, 2021 | National Cancer Institute (NCI), University of Washington |
| NCT04632537 | Phase 3 | Dec 7, 2020 | Department of Defense, Harvard University, Henry M. Jackson Foundation for the Advancement of Military Medicine, Uniformed Services University of the Health Sciences |
| NCT01868464 | Phase 1 | Jun 9, 2014 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02088892 | N/A | Mar 1, 2014 | Aeras, University of Birmingham, University of Oxford |
| NCT01340820 | Phase 1 | Dec 1, 2010 | Aeras, St. Louis University |
Showing 13 of 13 trials
Page 1 / 1
Organizations
Research & Development (25)
25 organizations
Page 1 / 2